Karsten Øvretveit, Marie Klevjer, Ben M Brumpton, Ulrik Wisløff, Kristian Hveem, Anja Bye
{"title":"Polygenic prediction of cardiorespiratory fitness: The HUNT Study.","authors":"Karsten Øvretveit, Marie Klevjer, Ben M Brumpton, Ulrik Wisløff, Kristian Hveem, Anja Bye","doi":"10.1101/2025.07.07.25330991","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiorespiratory fitness (CRF) has a strong genetic component and low CRF is a major risk factor for cardiovascular morbidity and mortality. The purpose of this study was to develop and validate a polygenic score (PGS) for CRF (CRF<sub>PGS</sub>) and assess its associations with cardiovascular disease (CVD) and all-cause mortality. We hypothesized that the CRF<sub>PGS</sub> would demonstrate similar cardioprotective benefits as the CRF phenotype.</p><p><strong>Methods: </strong>Effect estimates from a genome-wide association study on directly measured CRF in the Trøndelag Health Study (HUNT; <i>n</i> = 4 525) were used in a Bayesian regression framework to develop multiple PGSs in an independent cohort from the UK Biobank (<i>n</i> = 65 165). The top performing score was applied in the HUNT target cohort, excluding the discovery sample (<i>n</i> = 82 109).</p><p><strong>Results: </strong>The PGS-CRF association varied considerably as a function of model fit and phenotypic accuracy. In the target population, we observed a difference in CRF of 1.55 [95% confidence interval: 1.26, 1.84] mL·kg<sup>-1</sup>·min<sup>-1</sup> between the bottom and top decile of the CRF<sub>PGS</sub>. Moreover, a high CRF<sub>PGS</sub> demonstrated cardioprotective effects, with reduced risk for CVD, myocardial infarction, hypertension, and all-cause mortality. We also found that the CRF<sub>PGS</sub> predisposed to lower risk of heart failure and hypertrophic cardiomyopathy in women.</p><p><strong>Conclusion: </strong>A PGS for CRF derived from gold-standard phenotypes captures small, but potentially clinical meaningful variations in CRF, and is associated with reduced risk of cardiovascular morbidity and mortality. Heterogeneity in CRF phenotyping in large populations remains a challenge to PGS development and refinement.</p>","PeriodicalId":94281,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265795/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv : the preprint server for health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2025.07.07.25330991","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Cardiorespiratory fitness (CRF) has a strong genetic component and low CRF is a major risk factor for cardiovascular morbidity and mortality. The purpose of this study was to develop and validate a polygenic score (PGS) for CRF (CRFPGS) and assess its associations with cardiovascular disease (CVD) and all-cause mortality. We hypothesized that the CRFPGS would demonstrate similar cardioprotective benefits as the CRF phenotype.
Methods: Effect estimates from a genome-wide association study on directly measured CRF in the Trøndelag Health Study (HUNT; n = 4 525) were used in a Bayesian regression framework to develop multiple PGSs in an independent cohort from the UK Biobank (n = 65 165). The top performing score was applied in the HUNT target cohort, excluding the discovery sample (n = 82 109).
Results: The PGS-CRF association varied considerably as a function of model fit and phenotypic accuracy. In the target population, we observed a difference in CRF of 1.55 [95% confidence interval: 1.26, 1.84] mL·kg-1·min-1 between the bottom and top decile of the CRFPGS. Moreover, a high CRFPGS demonstrated cardioprotective effects, with reduced risk for CVD, myocardial infarction, hypertension, and all-cause mortality. We also found that the CRFPGS predisposed to lower risk of heart failure and hypertrophic cardiomyopathy in women.
Conclusion: A PGS for CRF derived from gold-standard phenotypes captures small, but potentially clinical meaningful variations in CRF, and is associated with reduced risk of cardiovascular morbidity and mortality. Heterogeneity in CRF phenotyping in large populations remains a challenge to PGS development and refinement.